High prevalence of chronic kidney disease in Iran: a large population-based study (Q33404464)

26 July 2017

title

High prevalence of chronic kidney disease in Iran: a large population-based study (English)

1 reference

chronic renal insufficiency

26 July 2017

main subject

1 reference

1 reference

4

Fereidoun Azizi

1 reference

26 July 2017

Farhad Hosseinpanah

1

1 reference

26 July 2017

Farshad Kasraei

series ordinal

2

1 reference

26 July 2017

Amir A Nassiri

series ordinal

3

1 reference

26 July 2017

language of work or name

English

0 references

publication date

31 January 2009

1 reference

26 July 2017

1 reference

26 July 2017

volume

9

1 reference

26 July 2017

page(s)

44

1 reference

Creative Commons Attribution 2.0 Generic

26 July 2017

copyright license

start time

31 January 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Prevalence and factors associated with CKD: a population study from Beijing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658666

High prevalence of chronic kidney disease in Thailand

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658666

Prevalence of chronic kidney disease in the United States

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658666

Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658666

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658666

Overview: obesity: what does it have to do with kidney disease?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658666

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658666

Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658666

Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658666

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658666

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658666

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658666

Management of patients with chronic renal insufficiency in the Northeastern United States.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658666

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658666

Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: important differences between practice and published guidelines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658666

Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-9-44

Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-9-44

Prevalence of kidney damage in Australian adults: The AusDiab kidney study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-9-44

Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-9-44

Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-9-44

Predictors of new-onset kidney disease in a community-based population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-9-44

Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-9-44

Influence of smoking and obesity on the development of proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-9-44

International comparison of the relationship of chronic kidney disease prevalence and ESRD risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-9-44

Serum creatinine as marker of kidney function in South Asians: a study of reduced GFR in adults in Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-9-44

Glycemic status and development of kidney disease: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-9-44

Why the MDRD equation should not be used in patients with normal renal function (and normal creatinine values)?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658666

Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials

31 October 2018

1 reference

12 December 2020

Risk factors for proteinuria in a large, multiracial, southeast Asian population

1 reference

12 December 2020

Chronic kidney disease and cardiovascular disease in the Medicare population

1 reference

12 December 2020

Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization

1 reference

12 December 2020

Body mass index and the risk of development of end-stage renal disease in a screened cohort

1 reference

12 December 2020

Diabetes mellitus. Report of a WHO Study Group

1 reference

12 December 2020

Blood pressure and end-stage renal disease in men

1 reference

12 December 2020

Hyperlipidemia in patients with chronic renal disease

1 reference

12 December 2020

Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes

1 reference

12 December 2020

Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2458-9-44

1 reference

Dimensions Publication ID

26 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2458-9-44

9 September 2019

1 reference

26 July 2017

1 reference